Advertisement

Topics

Search Results for "Who Manufactures Nilandron"

15:10 EST 7th December 2016 | BioPortfolio

Matching Channels

None

Matching News

ANI launches generic Nilandron

David SalazarANI’s is the first generic of the Nilandron, which is indicated to treat metastatic prostate cancer in combination with surgical castration.  read more

ANI Gets FDA Approval For First Generic Competitor to Nilandron

Announces immediate launch of nilutamide tablets

FDA approves first generic nilutamide for treatment of prostate cancer

US generics producer ANI Pharmaceuticals (ANI) announced on 18 July 2016 that it had received US Food and Drug Administration (FDA) approval for its generic version of prostate cancer treatment Niland...

BRIEF-ANI Pharmaceuticals announces FDA approval, launch of Nilutamide tablets

* ANI Pharmaceuticals announces FDA approval and immediate launch of Nilutamide tablets, the first generic competitor to Nilandron

Lannett Co. (LCI) Cut to Sell at Zacks Investment Research

According to Zacks, "Lannett, Inc. manufactures and distributes pharmaceutical products sold under generic names and historically has manufactured and distributed pharmaceutical products sold under it...

Lannett Co. (LCI) Rating Lowered to Sell at Zacks Investment Research

According to Zacks, "Lannett, Inc. manufactures and distributes pharmaceutical products sold under generic names and historically has manufactured and distributed pharmaceutical products sold under it...

Q Holdings in talks to buy Degania Silicone

The Israeli kibbutz company manufactures products for use in urological catheters and cardiology balloons.

Q Holdings in talks to buy Degania Silicone for $300m

The Israeli kibbutz company manufactures products for use in urological catheters and cardiology balloons.

Matching PubMed Articles

Industry Relationships With Pediatricians: Findings From the Open Payments Sunshine Act.

Ties between physicians and pharmaceutical/medical device manufactures have received considerable attention. The Open Payments program, part of the Affordable Care Act, requires public reporting of pa...

Portable System for Monitoring the Microclimate in the Footwear-Foot Interface.

A new, continuously-monitoring portable device that monitors the diabetic foot has shown to help in reduction of diabetic foot complications. Persons affected by diabetic foot have shown to be particu...

Circulating microRNAs found dysregulated in ex-exposed asbestos workers and pleural mesothelioma patients as potential new biomarkers.

Malignant pleural mesothelioma (MPM), a fatal cancer, is an occupational disease mostly affecting workers ex-exposed to asbestos fibers. The asbestos, a cancerogenic mineral of different chemical comp...

An Activity Index for Raw Accelerometry Data and Its Comparison with Other Activity Metrics.

Accelerometers have been widely deployed in public health studies in recent years. While they collect high-resolution acceleration signals (e.g., 10-100 Hz), research has mainly focused on summarized ...

Cabazitaxel for Hormone-Relapsed Metastatic Prostate Cancer Previously Treated With a Docetaxel-Containing Regimen: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

As part of its single technology appraisal (STA) process, the National Institute for Health and Care Excellence (NICE) invited the company that manufactures cabazitaxel (Jevtana(®), Sanofi, UK) to su...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement